These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33440095)

  • 1. Exercise Program Improves Functional Capacity and Quality of Life in Uncorrected Atrial Septal Defect-Associated Pulmonary Arterial Hypertension: A Randomized-Control Pilot Study.
    Rakhmawati A; Achmad IN; Hartopo AB; Anggrahini DW; Arso IA; Emoto N; Dinarti LK
    Ann Rehabil Med; 2020 Dec; 44(6):468-480. PubMed ID: 33440095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of oral sildenafil therapy on health-related quality of life in adults with pulmonary arterial hypertension related to uncorrected secundum atrial septal defect: a quasi experimental study.
    Hidayati F; Gharini PPR; Hartopo AB; Anggrahini DW; Dinarti LK
    Health Qual Life Outcomes; 2020 Aug; 18(1):278. PubMed ID: 32795300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum soluble suppression of tumorigenicity-2 level associates with severity of pulmonary hypertension associated with uncorrected atrial septal defect.
    Pratama RS; Hartopo AB; Anggrahini DW; Dewanto VC; Dinarti LK
    Pulm Circ; 2020; 10(2):2045894020915832. PubMed ID: 32518620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum.
    Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan.
    Rotondo C; Praino E; Nivuori M; di Serio F; Lapadula G; Iannone F
    Int J Rheum Dis; 2017 Jan; 20(1):90-96. PubMed ID: 26218502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of ambrisentan in Chinese patients with connective tissue disease-pulmonary arterial hypertension: a post-hoc analysis.
    Li M; Jing ZC; Li Y; Huo Y; Yu Z; Zhang G; Zhu P; Liu J; Ji Q; Wu B; Zhong J; Wang P; Zhu W; Zeng X
    BMC Cardiovasc Disord; 2020 Jul; 20(1):339. PubMed ID: 32680480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prescribed walking regimen plus arginine supplementation improves function and quality of life for patients with pulmonary arterial hypertension: a pilot study.
    Brown MB; Kempf A; Collins CM; Long GM; Owens M; Gupta S; Hellman Y; Wong V; Farber M; Lahm T
    Pulm Circ; 2018; 8(1):2045893217743966. PubMed ID: 29199900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of efficacy, safety and tolerability of Ambrisentan in Chinese adults with pulmonary arterial hypertension: a prospective open label cohort study.
    Huo Y; Jing ZC; Zeng XF; Liu JM; Yu ZX; Zhang GC; Li Y; Wang Y; Ji QS; Zhu P; Wu BX; Zheng Y; Wang PP; Li J
    BMC Cardiovasc Disord; 2016 Oct; 16(1):201. PubMed ID: 27770771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.
    McLaughlin VV; Benza RL; Rubin LJ; Channick RN; Voswinckel R; Tapson VF; Robbins IM; Olschewski H; Rubenfire M; Seeger W
    J Am Coll Cardiol; 2010 May; 55(18):1915-22. PubMed ID: 20430262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma N-terminal pro-brain natriuretic peptide levels are positively correlated with pulmonary arterial pressure in atrial septal defect patients.
    Li ZF; Zhou DX; Wang QB; Pan WZ; Zhang L; Ge JB
    Regul Pept; 2013 May; 183():13-6. PubMed ID: 23499807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individually Tailored Remote Physiotherapy Program Improves Participation and Autonomy in Activities of Everyday Life along with Exercise Capacity, Self-Efficacy, and Low-Moderate Physical Activity in Patients with Pulmonary Arterial Hypertension: A Randomized Controlled Study.
    Butāne L; Spilva-Ekerte L; Skride A; Šmite D
    Medicina (Kaunas); 2022 May; 58(5):. PubMed ID: 35630079
    [No Abstract]   [Full Text] [Related]  

  • 12. Exercise: a "new drug" for elderly patients with chronic heart failure.
    Antonicelli R; Spazzafumo L; Scalvini S; Olivieri F; Matassini MV; Parati G; Del Sindaco D; Gallo R; Lattanzio F
    Aging (Albany NY); 2016 May; 8(5):860-72. PubMed ID: 26953895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of the N-terminal pro-brain-type natriuretic peptide response to exercise with disease severity in therapy-naive pulmonary arterial hypertension: a cohort study.
    Kutsch J; Faul C; von Scheidt W; Schwaiblmair M; Berghaus TM
    Respir Res; 2018 Jan; 19(1):8. PubMed ID: 29334941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Macitentan in Patients With Eisenmenger Syndrome.
    Gatzoulis MA; Landzberg M; Beghetti M; Berger RM; Efficace M; Gesang S; He J; Papadakis K; Pulido T; Galiè N;
    Circulation; 2019 Jan; 139(1):51-63. PubMed ID: 30586694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted therapy is required for management of pulmonary arterial hypertension after defect closure in adult patients with atrial septal defect and associated pulmonary arterial hypertension.
    Fujino T; Yao A; Hatano M; Inaba T; Muraoka H; Minatsuki S; Imamura T; Maki H; Kinugawa K; Ono M; Nagai R; Komuro I
    Int Heart J; 2015; 56(1):86-93. PubMed ID: 25742945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of a simple home-based rehabilitation program in pulmonary arterial hypertension: an interventional pilot study.
    Wojciuk M; Ciolkiewicz M; Kuryliszyn-Moskal A; Chwiesko-Minarowska S; Sawicka E; Ptaszynska-Kopczynska K; Kaminski K
    BMC Sports Sci Med Rehabil; 2021 Jul; 13(1):79. PubMed ID: 34321095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment goals of pulmonary hypertension.
    McLaughlin VV; Gaine SP; Howard LS; Leuchte HH; Mathier MA; Mehta S; Palazzini M; Park MH; Tapson VF; Sitbon O
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D73-81. PubMed ID: 24355644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creation of a model comparing 6-minute walk test to metabolic equivalent in evaluating treatment effects in pulmonary arterial hypertension.
    Gomberg-Maitland M; Huo D; Benza RL; McLaughlin VV; Tapson VF; Barst RJ
    J Heart Lung Transplant; 2007 Jul; 26(7):732-8. PubMed ID: 17613405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of complex cardiac rehabilitation on physical activity and quality of life during long-term follow-up after surgical correction of congenital heart disease.
    Gierat-Haponiuk K; Haponiuk I; Szalewska D; Chojnicki M; Jaworski R; Niedoszytko P; Leszczyńska K; Bakuła S
    Kardiol Pol; 2015; 73(4):267-73. PubMed ID: 25371303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Riociguat for the treatment of pulmonary arterial hypertension.
    Ghofrani HA; Galiè N; Grimminger F; Grünig E; Humbert M; Jing ZC; Keogh AM; Langleben D; Kilama MO; Fritsch A; Neuser D; Rubin LJ;
    N Engl J Med; 2013 Jul; 369(4):330-40. PubMed ID: 23883378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.